Keywords: Ipsen, Spirogen, SJG-136, SG2000, Licensing

Ipsen and Spirogen revise deal for SJG-136 (now SG2000)

Article | 08 October 2009

Print This

French drugmaker Ipsen and the UK’s Spirogen have entered into a new agreement superseding their 2003 contractual relationship regarding the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in